Since 2015, ESOI has been proudly offering high quality webinars given by world class speakers on various topics in oncologic imaging. Our live webinars have been very well received by our members with consistently high turnout and engagement from participants all across the globe. After the presentation, you can even ask questions in real time!

ESOI webinars are oriented towards different levels of expertise, a wide array of topics, and are increasingly becoming more multidisciplinary.
A number of our webinars are carried out in collaboration with medical societies such as ESSO and ESTRO as well as other radiological subspecialty societies.
Young radiologists are also included in the webinar series with special sessions addressing relevant topics for residents.

In addition to the live broadcast, the lectures are uploaded to the Member Area (with an approximate one month delay) so they can be (re)viewed by active ESOI members at their own convenience.
To date, we have more than 80 full length lectures (with in-depth discussions and Q&A)!

Recommended Bandwidth
The website www.speedtest.net offers you to check your bandwidth. We strongly recommend
• Upload min. 6Mbit required bandwidth (relevant for speakers, moderators sharing their video&audio signal)
• Download min. 6Mbit required bandwidth
Also, we recommend a cable internet or a wireless connection with full signal.
Please note: Shared bandwidth (e.g. hospital, universities) will result in lower bandwidth for each user.

We are pleased to inform you that all regular webinars 2024 have been granted 1 European CME credit (ECMEC®s) by the European Accreditation Council for Continuing Medical Education (EACCME®).
Attendees need to attend the live webinar AND evaluate the webinar to receive the CME certificate.
The certificate of attendance/CME certificate will be sent approx. 1 week after the live webinar.

Webinar 8

Wednesday, September 25, 18:00 CEST
MDT discussion for cervical cancer
Speaker: Benedetta Gui, Rome/IT & Luca Russo, Rome/IT & Evis Sala, Rome/IT | Moderator: Marius Mayerhofer, New York/US

Webinar 9

Wednesday, October 23, 18:00 CEST
Non-invasive imaging in the diagnosis and prognosis prediction of liver cancer
Speaker: Yan Fuhua, Shanghai/CN | Moderator: Melvin D’Anastasi, Msida/MT

Webinar 10

Wednesday, December 11, 18:00 CET
MRI strategy on identification of tiny microadenoma of pituitary
Speaker: Feng Feng, Beijing/CN | Moderator: Lucien Beer, Vienna/AT

Webinar #1: Cystic pancreatic neoplasms: MDT

Giuseppe Malleo, Verona/IT & Giulia Zamboni, Verona/IT

Special Webinar #1: Urothelial cancer

Davide Prezzi, London/UK

Webinar #2: Imaging of mediastinal masses

Helmut Prosch, Vienna/AT

Webinar #3: Common errors in oncologic imaging

Daniele Regge, Torino/IT

Webinar #4: Imaging after nonsurgical therapies for non-small cell lung cancer: A guide for radiologists

Marie-Pierre Revel, Paris/FR; Anna Rita Larici, Rome/IT

Webinar #1: ESOI-ESSO-ESTRO: Rectal Cancer: A multi-disciplinary approach to imaging

Regina Beets-Tan, Geerard Beets; Amsterdam/NL

Webinar #2: Primary and secondary malignancies of the pleura: Diagnosis, staging and response assessment

Luciano Cardinale, Orbassano/IT

Webinar #3: Gastrointestinal cancers in IBD

Sofia Gourtsoyianni, Athens/GR

Webinar #4: Endometrial carcinoma

Milagros Otero-Garcia, Vigo/ES

Webinar #5: Whole-body diffusion weighted imaging

Vincent Vandecaveye, Leuven/BE

Special Webinar #1: Added value of artificial intelligence with CT and MRI for RCC diagnosis. 

Zhen Li, Wuhan/CN

Special Webinar #2: Hepatospecific contrast agents in the study of HCC: Is the examination time the most important aspect?

Jin Wang, Guangzhou/CN

Webinar #6: Atypical presentations of bone mets

Frederic Lecouvet, Brussels/BE

Special Webinar #3: AI-powered Screening/Prognosis/Diagnosis: What’s the future of Oncology Imaging?

Luis Marti-Bonmati, Valencia/ES

Webinar #7: Rad-path correlations in breast cancer

Alexandra Athanasiou, Athens/GR

Webinar #8: Nuclear medicine for the diagnosis and treatment of neuroendocrine tumors

Clemens Cyran, Munich/DE

Webinar #9: Role of imaging in esophageal cancer

Vicky Goh, London/UK

Webinar #10: Imaging and staging of laryngeal cancer

Minerva Becker, Geneva/CH

Webinar #11: Update in interventional oncology of HCC

Laura Crocetti, Pisa/IT

Webinar #12: Characterisation of the Small Solid Renal Mass: When you need MRI

Davide Prezzi, London/UK

Special Webinar #4: Parametric MR before prostate biopsy, may increase patient life with PSA increased level

Tobias Franiel, Jena/DE

Webinar #1: Multidisciplinary approach to small renal masses

Andrea Veltri, Orbassano/IT; Alessandro Volpe, Piedmont/IT; Marcello Tucci, Asti/IT

Webinar #2: O-Rads for MRI

Isabelle Thomassin-Naggara, Paris/FR

Webinar #3: Tumors and tumor-like lesions of the paranasal sinuses

Katarina Šurlan Popović, Ljubljana/SI

Webinar #4: Pediatric GI or GU tumors: A primer for the “adult radiologist”

Annemieke Littooij, Utrecht/NL; Irmina Sefic, Sarajevo/BA

Webinar #5: PET imaging evaluation in oncology: Tips & tricks for the clinical practice

André Dias, Aarhus/DK

Webinar #6: Cancer in pregnancy

Charis Bourgioti, Athens/GR

Webinar #7: Understanding Artificial Intelligence: Principles and basic concepts behind the “black box”

David Bonekamp, Hirschberg/DE

Webinar #8: Added value of PET/CT in staging and response assessment of head and neck tumors

Clemens Cyran, Munich/DE

Webinar #9: Abdominal toxicities of common oncologic therapies

Nina Tunariu, Tadworth/UK

Webinar #10: Incidental breast lesions at CT

Paola Clauser, Vienna/AT

Webinar #11: Life as an academic radiologist

Evis Sala, Cambridge/UK

Webinar #12: Skull base tumors: Differential diagnosis and key findings for treatment planning

Alexandra Borges, Lisbon/PT

Webinar #1: ESOI-ESSO-ESTRO: Rectal Cancer: A multi-disciplinary approach to imaging

R. Beets-Tan (Radiologist), G. Beets (Surgeon), C. Marijnen (Radiation oncologist); Amsterdam/NL

Webinar #2: Imaging of lymphomas: Current status

M. Mayerhöfer, New York/US

Webinar #3: ESOI-ESHI-MT: AI in multimodality imaging of cancer

C. Cyran, Munich/DE

Webinar #4: Multidisciplinary webinar: Preoperative assessment of peritoneal carcinomatosis

S. Nougaret, F. Quenet; Montpellier/FR

Webinar #5: NET: How to assess response to therapy – A case-based multidisciplinary discussion

D. Caruso, M. Rinzivillo; Rome/IT (case presenters); F. Panzuto, Rome/IT; M. Falconi, Milan/IT (panelists)

Webinar #6: Preparing and attending oncologic MDT meetings: A memorandum for the radiologist

L. Fournier, Paris/FR

Webinar #7: ESOI-EUSOBI: Surveillance after breast cancer treatment

Kristina Lang, Lund/SE

Webinar #8: Urologic webinar:
– Penile cancer: Role of MRI in the new 8th TNM staging system
– Testicular germ cell tumors: Staging and surveillance

Alberto Vargas, Sungmin Woo, Anton Becker; New York/US

Webinar #9: ESOI-ESNR: Brain metastases: Imaging after treatment

Pia Sundgren, Lund/Sweden

Webinar #10: ESOI-ESTI: Pulmonary complications in oncologic therapy
What the oncologic radiologist must know

Cornelia Schaefer-Prokop, Amersfoort/NL

Webinar #11
Imaging of HCC:
– Radiomics and radiogenomics in HCC
– Assessment of HCC response to therapy: New treatments, new challenges, new criteria

Emanuele Neri, Riccardo Lencioni; Pisa/IT

Limits and pitfalls of CT and MR in the staging of lung cancer

J. Dinkel, Munich/DE

Uterine tumours: Correlation between histology and imaging features

E. Sala (Radiologist), M. Jimenez-Linan (Pathologist); Cambridge/UK

A practical approach for the diagnosis of a liver tumor

V. Vilgrain, Paris/FR

Tumour board: GEP-NET

A. Laghi (Radiologist), D. Caruso (Radiologist), F. Panzuto (Gastroenterologist), M. Rinzivillo (Gastroenterologist); Rome/IT
M. Falconi, Milan/IT (Surgeon)

MSK – soft tissues tumours

F. Vanhoenacker, Antwerp/BE

Role of cardiac imaging (CT and MRI) in patients with cancer

B. Velthuis, Utrecht/NL

Spinal tumours

L. van den Hauwe, Antwerp/BE

Imaging biomarkers in oncology

A. Alberich-Bayarri, Valencia/ES

Multidisciplinary Webinar from ESOI-ESTRO
Lung cancer: A multidisciplinary approach to imaging

A.R. Larici (Radiologist), V. Valentini (Radiation Oncologist); Rome/IT

Oncologic Imaging and Covid-19: An unwanted wedding

D. Regge, Turin/IT; D. Caruso, Rome/IT

Imaging in gastric cancer before and after neoadjuvant therapy

M.A. Mazzei, Siena/IT

ESOI Young Radiologists’ Webinar: Basic statistics

M. Maas, Amsterdam/NL

Prostate cancer: A multidisciplinary approach to imaging

H-P. Schlemmer (Radiologist), J.P. Radtke (Urologist); Heidelberg/DE

Immune therapy: Response assessment and toxicity

D. Regge, Turin/IT

Small bowel tumours

M. Gollub, New York/US

Interventional oncological options for RCC

M. Krokidis, Cambridge/UK

Rectal cancer: A multidisciplinary approach to imaging

R. Beets-Tan, Amsterdam/NL (Radiologist), N. Figueiredo, Lisbon/PT (Surgeon), R. Glynne-Jones, Northwood/UK (Radiation Oncologist)

Imaging and response assessment of multiple myeloma

A. Baur-Melnyk, Munich/DE

Artificial intelligence in oncologic imaging: Current status and future directions

E. Neri, Pisa/IT (Radiologist); A. Alberich Bayarri, Valencia/ES (Telecommunications Engineer)

Clinical relevance of PSMA PET/CT: An overview and update

C. Cyran, Munich/DE

Assessing response to therapy of brain tumours

P.M. Sundgren, Lund/SE

Pancreatic cancer: A multidisciplinary approach to imaging

G. Zamboni (Radiologist), G. Marchegiani (Surgeon); Verona/IT

Breast cancer: A multidisciplinary approach to imaging in neoadjuvant treatment

M. Lobbes, Sittard-Geleen/NL (Radiologist); M.L. Smidt, Maastricht/NL (Surgeon)

Interventional oncological treatment of lung nodules/lung cancer

J. Palussière, Bordeaux/FR

New paradigms in scientific publishing

M.F. Reiser, Munich/DE

Correlation of radiological images with surgical findings in ovarian peritoneal disease

L. Fournier (Radiologist), A.S. Bats (Surgeon); Paris/FR

Rectal Cancer: A multidisciplinary approach to imaging

R. Beets-Tan (Radiologist), G. Beets (Surgeon), B. van Triest (Radiation oncologist); Amsterdam/NL

Cross-sectional imaging of renal tumours

R. Pozzi Mucelli, Verona/IT

Structured reporting in prostate cancer

D. Regge, Turin/IT

Imaging of testicular tumours

M. Bertolotto, Trieste/IT

Preoperative local staging of breast cancer: tailoring the surgical treatment

J. Camps Herrero, Alzira/ES (Radiologist); R. Ponzone, Turin/IT (Surgeon)

Response evaluation in oncology: RECIST 1.1

M. D’Anastasi, Msida/MT

Algorithmic approach to the female pelvic mass

E. Sala, Cambridge/UK

Molecular and hybrid imaging in prostate cancer

G. Cook, London/UK

Rectal cancer: A multidisciplinary approach to imaging

R. Beets-Tan (Radiologist), G. Beets (Surgeon), B. van Triest (Radiation oncologist); Amsterdam/NL

Diagnosis and staging of oesophageal and gastric cancer

M. Laniado, Dresden/DE

Neuroendocrine tumours – radionuclide imaging and therapy

H. Ilhan, Munich/DE

Structured reporting in rectal cancer

M. Maas, Amsterdam/NL

Imaging after treatment of lung cancer

J. Dinkel, Munich/DE

Multidisciplinary management of CRC liver metastases

Th. Helmberger, Munich/DE

Lung cancer screening – what did we learn so far?

C. Schaefer-Prokop, Amersfoort/NL

Assessment of the treatment response of bone lesions in cancer patients: Pearls and pitfalls

F. Lecouvet, Brussels/BE

Imaging and response assessment of gastrointestinal stromal tumours

A. Laghi, Rome/IT

Imaging of CNS tumours

P. Parizel, Antwerp/BE

Imaging and differential diagnosis of orbital tumours

U. Mueller-Lisse, Munich/DE

Imaging of lymphomas

M. Mayerhöfer, Vienna/AT

Imaging spectrum of primary and secondary mesenteric neoplasms

S. Nougaret, Montpellier/FR

Imaging of the treated pelvis: Pearls and pitfalls

E. Sala, New York/US

MR imaging of malignant diseases of the uterus

Y. Lakhman, New York/US

Practical advice in preparing successful scientific manuscripts

M.F. Reiser, Munich/DE

Imaging of recurrent prostate cancer

H. Vargas, New York/US

Bone metastases, how should we approach them with imaging?

T. Bäuerle, Erlangen/DE

PET-MRI in oncologic imaging – where do we stand?

V. Goh, London/UK

When to call a lesion an HCC?

G. Brancatelli, Palermo/IT

Current evidence for minimally invasive treatments in HCC

J. Ricke, Munich/DE

Diagnostic test studies: How I do it

M. Maas, Amsterdam/NL

Paediatric abdominal tumours

C. Granata, Genoa/IT

Staging of rectal cancer with MRI

R. Beets-Tan, Amsterdam/NL

Contrast-enhanced ultrasound-technical considerations and applications in oncologic imaging

D. Clevert, Munich/DE

Imaging dissemination pathways in head and neck cancer

M. Mack, Munich/DE

Whole body MRI in onology

V. Vandecaveye, Leuven/BE

Imaging of lung cancer: Implications on management

L. Bonomo, Rome/IT

Imaging of biliary tract tumours

R. Manfredi, Verona/IT

Staging of ovarian cancer – providing a GPS to patient management

H. Hricak, New York/US

Role of MRI in the diagnosis and management of prostate cancer

H. Vargas, New York/US

Tailoring breast imaging surveillance to the woman´s risk

F. Gilbert, Cambridge/UK

Imaging of bone tumours

G. Guglielmi, Foggia/IT

RECIST, CHOI and beyond

M. D’Anastasi, Munich/DE

DW in oncologic imaging

D. Lambregts, Maastricht/NL

CT colonography

A. Laghi, Latina/IT

Cystic and solid pancreatic tumors

G. Zamboni, Verona/IT

Imaging the prostate – current status and future developments

J. Futterer, Nijmengen/NL

Update on breast MRI

F. Sardanelli, Milan/IT

Structured oncologic reporting

W. Sommer, Munich/DE